TY - JOUR
T1 - Defining an International Standard Set of Outcome Measures for Patients With Hip or Knee Osteoarthritis
T2 - Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working Group
AU - Rolfson, Ola
AU - Wissig, Stephanie
AU - van Maasakkers, Lisa
AU - Stowell, Caleb
AU - Ackerman, Ilana
AU - Ayers, David
AU - Barber, Thomas
AU - Benzakour, Thami
AU - Bozic, Kevin
AU - Budhiparama, Nicolaas
AU - Caillouette, James
AU - Conaghan, Philip G.
AU - Dahlberg, Leif
AU - Dunn, Jennifer
AU - Grady-Benson, John
AU - Ibrahim, Said A.
AU - Lewis, Sally
AU - Malchau, Henrik
AU - Manzary, Mojieb
AU - March, Lyn
AU - Nassif, Nader
AU - Nelissen, Rob
AU - Smith, Noel
AU - Franklin, Patricia Durkin
N1 - Publisher Copyright:
© 2016, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Objective: To define a minimum Standard Set of outcome measures and case-mix factors for monitoring, comparing, and improving health care for patients with clinically diagnosed hip or knee osteoarthritis (OA), with a focus on defining the outcomes that matter most to patients. Methods: An international working group of patients, arthroplasty register experts, orthopedic surgeons, primary care physicians, rheumatologists, and physiotherapists representing 10 countries was assembled to review existing literature and practices for assessing outcomes of pharmacologic and nonpharmacologic OA therapies, including surgery. A series of 8 teleconferences, incorporating a modified Delphi process, were held to reach consensus. Results: The working group reached consensus on a concise set of outcome measures to evaluate patients’ joint pain, physical functioning, health-related quality of life, work status, mortality, reoperations, readmissions, and overall satisfaction with treatment result. To support analysis of these outcome measures, pertinent baseline characteristics and risk factor metrics were defined. Annual outcome measurement is recommended for all patients. Conclusion: We have defined a Standard Set of outcome measures for monitoring the care of people with clinically diagnosed hip or knee OA that is appropriate for use across all treatment and care settings. We believe this Standard Set provides meaningful, comparable, and easy to interpret measures ready to implement in clinics and/or registries globally. We view this set as an initial step that, when combined with cost data, will facilitate value-based health care improvements in the treatment of hip and knee OA.
AB - Objective: To define a minimum Standard Set of outcome measures and case-mix factors for monitoring, comparing, and improving health care for patients with clinically diagnosed hip or knee osteoarthritis (OA), with a focus on defining the outcomes that matter most to patients. Methods: An international working group of patients, arthroplasty register experts, orthopedic surgeons, primary care physicians, rheumatologists, and physiotherapists representing 10 countries was assembled to review existing literature and practices for assessing outcomes of pharmacologic and nonpharmacologic OA therapies, including surgery. A series of 8 teleconferences, incorporating a modified Delphi process, were held to reach consensus. Results: The working group reached consensus on a concise set of outcome measures to evaluate patients’ joint pain, physical functioning, health-related quality of life, work status, mortality, reoperations, readmissions, and overall satisfaction with treatment result. To support analysis of these outcome measures, pertinent baseline characteristics and risk factor metrics were defined. Annual outcome measurement is recommended for all patients. Conclusion: We have defined a Standard Set of outcome measures for monitoring the care of people with clinically diagnosed hip or knee OA that is appropriate for use across all treatment and care settings. We believe this Standard Set provides meaningful, comparable, and easy to interpret measures ready to implement in clinics and/or registries globally. We view this set as an initial step that, when combined with cost data, will facilitate value-based health care improvements in the treatment of hip and knee OA.
UR - http://www.scopus.com/inward/record.url?scp=84984883823&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984883823&partnerID=8YFLogxK
U2 - 10.1002/acr.22868
DO - 10.1002/acr.22868
M3 - Article
C2 - 26881821
AN - SCOPUS:84984883823
SN - 2151-464X
VL - 68
SP - 1631
EP - 1639
JO - Arthritis Care and Research
JF - Arthritis Care and Research
IS - 11
ER -